Time Dependent Factor IX Inhibitor

Bitte kopieren Sie die angezeigte URL und fügen sie dann in Ihren RSS-Reader ein.

Thromb Haemost 1989; 62(04): 1151
DOI: 10.1055/s-0038-1647137

Letter to the Editor

Schattauer GmbH Stuttgart

Authors

Ravindra Sarode

The Department of Hematology, Postgraduate Institute of Medical Education & Research, Chandigarh 160 012, India
A P Chauhan

The Department of Hematology, Postgraduate Institute of Medical Education & Research, Chandigarh 160 012, India
Mr Joseph

The Department of Hematology, Postgraduate Institute of Medical Education & Research, Chandigarh 160 012, India
Neelam Marwaha

The Department of Hematology, Postgraduate Institute of Medical Education & Research, Chandigarh 160 012, India
S K Sharma

The Department of Hematology, Postgraduate Institute of Medical Education & Research, Chandigarh 160 012, India
S Dash

The Department of Hematology, Postgraduate Institute of Medical Education & Research, Chandigarh 160 012, India

Received 26. Mai 1989

Accepted after revision 27. September 1989

Publikationsdatum:
24. Juli 2018 (online)

References
1 Hassan HJ, Leonardie A, Gueeriero R. et al Hemophilia ‘B’ with inhibitor: molecular analysis of the subtotal deletion of factor IX gene. Blood 1985; 66: 728-730

Reference Link Ris
PubMed Suche in Google Scholar
2 Shapiro SS. Antibodies to blood coagulation factor. Clinics Hematol 1979; 08 (01) 210

Reference Link Ris
PubMed Suche in Google Scholar
3 Gadarowski Jr JJ, Czapek EE, Ontiveros JD, Pedraza JL. Modification of the Bethesda assay for factor VIII or IX inhibitors to improve efficacy. Acta Hematol 1988; 80: 134-138

Reference Link Ris
Crossref PubMed Suche in Google Scholar